Hyper-blebbing nOMVs via Flippase Overexpression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing native outer membrane vesicles (nOMVs) are limited by low yields, making them impractical for commercial vaccine production, and detergent-extracted OMVs (dOMVs) are costly due to detergent requirements and lack of lipoproteins, which are immunologically significant.
Innovation Solution
Genetically modified Gram-negative bacteria that over-express or constitutively express a flippase, leading to hyper-blebbing and increased production of nOMVs with higher surface-exposed lipoproteins, such as Neisseria meningitidis, to enhance vaccine production and immune response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If nOMVs are isolated from culture medium using conventional methods, then the vesicles maintain native membrane structure with lipoproteins, but the production yield is too low for commercial vaccine production
Solution Approach 1:
The invention modifies bacterial strain parameters by deleting specific genes (gna33 in Neisseria, tolR in Shigella/Salmonella) to create hyper-blebbing phenotypes that naturally increase OMV production. This genetic parameter change enables commercial-scale production while preserving native membrane structure and lipoprotein content without requiring detergent extraction
Solution Approach 2:
The invention selectively removes specific genes (gna33, tolR) from the bacterial genome to induce hyper-blebbing phenotype. This targeted genetic extraction creates strains that spontaneously produce large quantities of OMVs with enhanced surface-exposed lipoproteins, solving the low yield problem while maintaining structural integrity
2Productivity
If detergent extraction is used to produce OMVs, then production cost increases due to detergent requirements, but the process can handle larger volumes
Solution Approach 1:
The hyper-blebbing bacterial strains spontaneously and continuously produce large quantities of OMVs that self-release into the culture medium. This self-service mechanism eliminates the need for detergent extraction, reducing production costs while maintaining high productivity and native lipoprotein content
3Quantity of substance
If conventional nOMV production methods are used, then lipoproteins are preserved on the vesicle surface, but the amount of vesicles produced is insufficient for practical vaccine application
Solution Approach 1:
By deleting gna33 or tolR genes, the invention changes the bacterial physiological parameters to induce hyper-blebbing phenotype. This parameter change simultaneously increases total vesicle production and enhances the surface exposure of lipoproteins, solving both the quantity and productivity problems
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified bacteria produce nOMVs with enriched lipoproteins, improving immune response and reducing the amount needed for vaccination, thus increasing vaccine efficacy and reducing production costs.
Implementation Method 1
Genetically modified Gram-negative bacteria that over-express or constitutively express a flippase, leading tohyper-blebbing and increased production of nOMVs with higher surface-exposed lipoproteins
Data Source
AI summary
The present invention relates to the field of native outer membrane vesicles (nOMVs), particularly nOMVs having increased levels of lipoproteins on their surface and use of same in immunogenic compositions.